Search Results - "Elkaeed, Eslam B."

Refine Results
  1. 1

    Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization by Abo Elmaaty, Ayman, Hamed, Mohammed I A, Ismail, Muhammad I, B Elkaeed, Eslam, S Abulkhair, Hamada, Khattab, Muhammad, Al-Karmalawy, Ahmed A

    Published in Molecules (Basel, Switzerland) (21-06-2021)
    “…The discovery of drugs capable of inhibiting SARS-CoV-2 is a priority for human beings due to the severity of the global health pandemic caused by COVID-19. To…”
    Get full text
    Journal Article
  2. 2

    Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects by Elkaeed, Eslam B., Yousef, Reda G., Elkady, Hazem, Gobaara, Ibraheem M. M., Alsfouk, Bshra A., Husein, Dalal Z., Ibrahim, Ibrahim M., Metwaly, Ahmed M., Eissa, Ibrahim H.

    Published in Molecules (Basel, Switzerland) (19-07-2022)
    “…A nicotinamide-based derivative was designed as an antiproliferative VEGFR-2 inhibitor with the key pharmacophoric features needed to interact with the VEGFR-2…”
    Get full text
    Journal Article
  3. 3

    Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor by Al-Karmalawy, Ahmed A., Dahab, Mohammed A., Metwaly, Ahmed M., Elhady, Sameh S., Elkaeed, Eslam B., Eissa, Ibrahim H., Darwish, Khaled M.

    Published in Frontiers in chemistry (04-05-2021)
    “…The rapid and global spread of a new human coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has produced an immediate urgency to…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) by Alesawy, Mohamed S., Abdallah, Abdallah E., Taghour, Mohammed S., Elkaeed, Eslam B., H. Eissa, Ibrahim, Metwaly, Ahmed M.

    Published in Molecules (Basel, Switzerland) (10-05-2021)
    “…The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the “COVID-19” disease that has been declared by WHO as a global emergency. The…”
    Get full text
    Journal Article
  7. 7

    In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies by Alesawy, Mohamed S, Elkaeed, Eslam B, Alsfouk, Aisha A, Metwaly, Ahmed M, Eissa, Ibrahim H

    Published in Molecules (Basel, Switzerland) (30-10-2021)
    “…Papain-like protease is an essential enzyme in the proteolytic processing required for the replication of SARS-CoV-2. Accordingly, such an enzyme is an…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease by Elkaeed, Eslam B., Eissa, Ibrahim H., Elkady, Hazem, Abdelalim, Ahmed, Alqaisi, Ahmad M., Alsfouk, Aisha A., Elwan, Alaa, Metwaly, Ahmed M.

    “…Among a group of 310 natural antiviral natural metabolites, our team identified three compounds as the most potent natural inhibitors against the SARS-CoV-2…”
    Get full text
    Journal Article
  10. 10

    In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10 by Eissa, Ibrahim H., Khalifa, Mohamed M., Elkaeed, Eslam B., Hafez, Elsayed E., Alsfouk, Aisha A., Metwaly, Ahmed M.

    Published in Molecules (Basel, Switzerland) (12-10-2021)
    “…In continuation of our previous effort, different in silico selection methods were applied to 310 naturally isolated metabolites that exhibited antiviral…”
    Get full text
    Journal Article
  11. 11

    Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease by Elkaeed, Eslam B., Youssef, Fadia S., Eissa, Ibrahim H., Elkady, Hazem, Alsfouk, Aisha A., Ashour, Mohamed L., El Hassab, Mahmoud A., Abou-Seri, Sahar M., Metwaly, Ahmed M.

    “…In continuation of our antecedent work against COVID-19, three natural compounds, namely, Luteoside C (130), Kahalalide E (184), and Streptovaricin B (278)…”
    Get full text
    Journal Article
  12. 12

    New Anticancer Theobromine Derivative Targeting EGFRWT and EGFRT790M: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies by Elkaeed, Eslam B., Yousef, Reda G., Elkady, Hazem, Alsfouk, Aisha A., Husein, Dalal Z., Ibrahim, Ibrahim M., Metwaly, Ahmed M., Eissa, Ibrahim H.

    Published in Molecules (Basel, Switzerland) (09-09-2022)
    “…Based on the pharmacophoric features of EGFR inhibitors, a new semisynthetic theobromine-derived compound was designed to interact with the catalytic pocket of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation by Hagras, Mohamed, El Deeb, Moshira A., Elzahabi, Heba S. A., Elkaeed, Eslam B., Mehany, Ahmed B. M., Eissa, Ibrahim H.

    “…Discovering of new anticancer agents with potential activity against tubulin polymerisation is still a promising approach. Colchicine binding site inhibitors…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20